Cascadian Therapeutics Inc (CASC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2005 | 03-2005 | 12-2004 | 09-2004 | 06-2004 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,910 | -3,600 | -10,150 | -3,770 | -2,860 |
| Depreciation Amortization | 60 | 60 | 340 | 70 | -4,650 |
| Other Working Capital | -250 | -120 | -1,370 | 20 | -860 |
| Other Operating Activity | 140 | -20 | -4,070 | 710 | 360 |
| Operating Cash Flow | $-3,960 | $-3,680 | $-15,250 | $-2,970 | $-8,010 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -70 | -30 | -100 | -30 | -50 |
| Other Investing Activity | -6,780 | 510 | -1,510 | 2,920 | -4,910 |
| Investing Cash Flow | $-6,850 | $480 | $-1,610 | $2,890 | $-4,960 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 770 | -40 | 13,600 | -10 | -10 |
| Financing Cash Flow | $770 | $-40 | $13,600 | $-10 | $-10 |
| Exchange Rate Effect | -20 | 40 | -200 | -80 | 50 |
| Beginning Cash Position | 13,060 | 16,430 | 19,990 | 5,260 | 17,950 |
| End Cash Position | 2,980 | 13,230 | 16,520 | 5,090 | 4,990 |
| Net Cash Flow | $-10,070 | $-3,200 | $-3,460 | $-170 | $-12,950 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,960 | -3,680 | -15,250 | -2,970 | -8,010 |
| Free Cash Flow | -3,960 | -3,680 | -15,250 | -2,970 | -8,010 |